Arthritis Hot

Description

Arthritis Penetrating Pain Relief Cream is formulated for topical application and is indicated for the relief of pain associated with arthritis. The product is packaged in a net weight of 3 ounces (85 grams). The National Drug Code (NDC) for this formulation is 41167-0600-4.

Uses and Indications

This drug is indicated for the temporary relief of minor pain associated with various conditions, including arthritis, simple backache, muscle strains, sprains, bruises, and cramps.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children over 12 years of age, a thin layer of the medication should be applied to the affected area. The application should be followed by gentle massage into the painful area until the product is thoroughly absorbed into the skin. This process may be repeated as necessary, but should not exceed 3 to 4 applications per day. In the event that the medication comes into contact with the hands, it is important to wash the hands with soap and water immediately.

For children 12 years of age or younger, it is advised to consult a physician before use.

Contraindications

The product should not be used in the following situations:

• Tight bandaging or the application of local heat (e.g., heating pads) to the area of use is contraindicated, as it may exacerbate adverse effects.

• Contact with eyes and mucous membranes must be avoided to prevent irritation or injury.

• Application to wounds or damaged, broken, or irritated skin is contraindicated due to the risk of further skin damage or infection.

• Exposure of the treated area to heat or direct sunlight should be avoided to prevent potential adverse reactions.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to consult a doctor prior to use if they have a history of allergic reactions to aspirin or salicylates. It is important to note that rare cases of serious burns have been reported with products of this type.

Patients must use the product strictly as directed, adhering to all instructions and warnings provided on the label. It is crucial to avoid bandaging the area tightly or applying local heat, such as heating pads or medicated patches, to the site of application. Contact with eyes and mucous membranes should be avoided, and the product must not be applied to wounds or areas of damaged, broken, or irritated skin.

A transient burning sensation may occur upon application; however, this typically resolves within several days. Should a severe burning sensation arise, patients are advised to discontinue use immediately. Additionally, the treated area should not be exposed to heat or direct sunlight.

In the event of ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Patients should be instructed to stop using the product and contact their healthcare provider if any of the following occur: worsening of the condition, presence of redness, development of irritation, persistence of symptoms beyond 7 days, recurrence of symptoms after initial improvement, or any signs of skin injury, including pain, swelling, or blistering at the application site.

Side Effects

Patients using this product should be aware of several potential adverse reactions. For external use only, the product carries an allergy alert; individuals with a known sensitivity to aspirin or salicylates are advised to consult a healthcare professional prior to use.

In clinical experiences, rare cases of serious burns have been reported with similar products. Additionally, a transient burning sensation may occur upon application, which typically resolves within several days. However, if a severe burning sensation is experienced, patients should discontinue use immediately.

Patients are advised to stop using the product and consult a doctor if any of the following occur: worsening of the condition, presence of redness, development of irritation, persistence of symptoms beyond 7 days, or if symptoms clear up only to recur within a few days. Furthermore, any signs of skin injury, such as pain, swelling, or blistering at the application site, warrant immediate medical attention.

Drug Interactions

Patients with a known allergy to aspirin or salicylates should consult a healthcare professional prior to use, as there is a potential risk of allergic reactions.

No specific drug or laboratory test interactions have been identified in the available data. Therefore, routine monitoring or dosage adjustments related to drug interactions are not indicated at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Arthritis Hot (menthol and methyl salicylate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients 12 years of age or younger should consult a healthcare professional before use. It is important to assess the appropriateness of treatment and dosage for this age group, as specific recommendations may vary based on individual health needs and conditions.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to assess the potential risks and benefits associated with its use during pregnancy and lactation. The safety of this medication in pregnant women has not been established, and caution is advised to ensure the well-being of both the mother and the fetus.

Lactation

Lactating mothers are advised to consult a healthcare professional prior to using this medication. There is currently no available data regarding the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment may not have specific information regarding dosage adjustments, special monitoring, or safety considerations outlined in the prescribing information. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment and individualized patient assessment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdose, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should be contacted without delay, or the individual should reach out to a Poison Control Center for guidance.

Symptoms of overdose may vary depending on the specific substance involved; therefore, it is essential to monitor the patient closely for any signs of adverse reactions. Prompt recognition of symptoms can facilitate timely intervention and improve outcomes.

Management of an overdose typically involves supportive care and symptomatic treatment. Healthcare providers should assess the patient's condition and implement appropriate measures based on the severity of the symptoms and the substance involved.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed to stop using the product and consult a doctor if any of the following occur: the condition worsens, redness is present, irritation develops, symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days. Additionally, patients should seek medical advice if they experience signs of skin injury, such as pain, swelling, or blistering at the application site.

When using this product, patients must be instructed to use it only as directed and to read and follow all directions and warnings on the label. It is important to note that rare cases of serious burns have been reported with similar products. Patients should be cautioned against bandaging the area tightly or applying local heat, such as heating pads or medicated patches, to the treated area.

Healthcare providers should emphasize the importance of avoiding contact with eyes and mucous membranes, and that the product should not be applied to wounds or damaged, broken, or irritated skin. Patients may experience a transient burning sensation upon application, which typically resolves within several days. However, if a severe burning sensation occurs, they should discontinue use immediately. Lastly, patients should be advised to avoid exposing the treated area to heat or direct sunlight.

Storage and Handling

The product is supplied in configurations that include specific NDC numbers. It should be stored at room temperature, ensuring that it is protected from light exposure. Freezing the product is not permitted, as it may compromise its integrity. Once opened, the product must be discarded to ensure safety and efficacy.

Additional Clinical Information

The product is administered topically, with adults and children over 12 years advised to apply it generously to the affected area and massage until fully absorbed. This application may be repeated as necessary, but should not exceed 3 to 4 times daily. For children aged 12 years or younger, consultation with a doctor is recommended prior to use.

Clinicians should counsel patients on potential allergies, particularly those with a history of reactions to aspirin or salicylates, and advise pregnant or breastfeeding individuals to seek professional guidance before use. It is important to keep the product out of reach of children, and in the event of ingestion, immediate medical assistance or contact with a Poison Control Center is necessary.

Drug Information (PDF)

This file contains official product information for Arthritis Hot, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)